Cargando…

Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients

BACKGROUND: Fatigue is one of the most debilitating symptoms in multiple sclerosis (MS) considerably interfering with patients’ daily functioning. Both researchers and clinicians need psychometrically robust methods to evaluate fatigue in MS. OBJECTIVES: The objective of this study was (i) to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosti‐Otajärvi, Eija, Hämäläinen, Päivi, Wiksten, Anna, Hakkarainen, Tanja, Ruutiainen, Juhani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516613/
https://www.ncbi.nlm.nih.gov/pubmed/28729945
http://dx.doi.org/10.1002/brb3.743
_version_ 1783251193712082944
author Rosti‐Otajärvi, Eija
Hämäläinen, Päivi
Wiksten, Anna
Hakkarainen, Tanja
Ruutiainen, Juhani
author_facet Rosti‐Otajärvi, Eija
Hämäläinen, Päivi
Wiksten, Anna
Hakkarainen, Tanja
Ruutiainen, Juhani
author_sort Rosti‐Otajärvi, Eija
collection PubMed
description BACKGROUND: Fatigue is one of the most debilitating symptoms in multiple sclerosis (MS) considerably interfering with patients’ daily functioning. Both researchers and clinicians need psychometrically robust methods to evaluate fatigue in MS. OBJECTIVES: The objective of this study was (i) to evaluate the psychometric properties of the Finnish version of the Fatigue Severity Scale (FSS) and (ii) to describe the results among patients with MS. METHODS: In total, 553 patients with MS (mean age, 53.8 years; standard deviation [SD], 11.4; 79% women: mean patient‐defined disease severity, Expanded Disability Status Scale [EDSS] 4.0, SD, 2.5) completed the self‐administered questionnaires including the FSS. A standard procedure was used for the translation of the FSS. RESULTS: The mean (SD) score for the FSS was 4.5 (1.7); in 65% of the patients, the score was ≥4.0. The data quality of the FSS was excellent, with 99.6% of computable scale scores. Floor and ceiling effects were minimal. The FSS showed high internal consistency (Cronbach's alpha, 0.95). Unidimensionality was supported based on confirmatory factor analysis with the comparative fit index being 0.94. The FSS showed moderate/high correlations with the perceived burden of the disease, quality of life and disease severity, whereas, age or gender did not have a significant effect on the FSS score. CONCLUSIONS: The Finnish version of the FSS showed satisfactory reliability and validity and thus can be regarded as a feasible measure of self‐reported fatigue.
format Online
Article
Text
id pubmed-5516613
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55166132017-07-20 Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients Rosti‐Otajärvi, Eija Hämäläinen, Päivi Wiksten, Anna Hakkarainen, Tanja Ruutiainen, Juhani Brain Behav Original Research BACKGROUND: Fatigue is one of the most debilitating symptoms in multiple sclerosis (MS) considerably interfering with patients’ daily functioning. Both researchers and clinicians need psychometrically robust methods to evaluate fatigue in MS. OBJECTIVES: The objective of this study was (i) to evaluate the psychometric properties of the Finnish version of the Fatigue Severity Scale (FSS) and (ii) to describe the results among patients with MS. METHODS: In total, 553 patients with MS (mean age, 53.8 years; standard deviation [SD], 11.4; 79% women: mean patient‐defined disease severity, Expanded Disability Status Scale [EDSS] 4.0, SD, 2.5) completed the self‐administered questionnaires including the FSS. A standard procedure was used for the translation of the FSS. RESULTS: The mean (SD) score for the FSS was 4.5 (1.7); in 65% of the patients, the score was ≥4.0. The data quality of the FSS was excellent, with 99.6% of computable scale scores. Floor and ceiling effects were minimal. The FSS showed high internal consistency (Cronbach's alpha, 0.95). Unidimensionality was supported based on confirmatory factor analysis with the comparative fit index being 0.94. The FSS showed moderate/high correlations with the perceived burden of the disease, quality of life and disease severity, whereas, age or gender did not have a significant effect on the FSS score. CONCLUSIONS: The Finnish version of the FSS showed satisfactory reliability and validity and thus can be regarded as a feasible measure of self‐reported fatigue. John Wiley and Sons Inc. 2017-06-09 /pmc/articles/PMC5516613/ /pubmed/28729945 http://dx.doi.org/10.1002/brb3.743 Text en © 2017 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Rosti‐Otajärvi, Eija
Hämäläinen, Päivi
Wiksten, Anna
Hakkarainen, Tanja
Ruutiainen, Juhani
Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
title Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
title_full Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
title_fullStr Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
title_full_unstemmed Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
title_short Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
title_sort validity and reliability of the fatigue severity scale in finnish multiple sclerosis patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516613/
https://www.ncbi.nlm.nih.gov/pubmed/28729945
http://dx.doi.org/10.1002/brb3.743
work_keys_str_mv AT rostiotajarvieija validityandreliabilityofthefatigueseverityscaleinfinnishmultiplesclerosispatients
AT hamalainenpaivi validityandreliabilityofthefatigueseverityscaleinfinnishmultiplesclerosispatients
AT wikstenanna validityandreliabilityofthefatigueseverityscaleinfinnishmultiplesclerosispatients
AT hakkarainentanja validityandreliabilityofthefatigueseverityscaleinfinnishmultiplesclerosispatients
AT ruutiainenjuhani validityandreliabilityofthefatigueseverityscaleinfinnishmultiplesclerosispatients